Insider filing · ADMA

Steve Elms sold $8.8M of Adma Biologics (ADMA)

Executed Jun 12 2025, disclosed Jun 16 2025, 4 days later.

Returns are measured on stock purchases only.

SE Steve Elms Director profile →

Steve Elms (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ADMA. Across 1 priced purchase filing, the average 21-session return was -44.2% from execution and -40.9% from disclosure (delay-adjusted; derived). The largest single filing was $217K of ADMA (14,000 sh across 2 lots, as filed), executed Mar 5.

ADMA ADMA ADMA · 22 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→